» Articles » PMID: 23403990

The Effectiveness of the Oncolytic Activity Induced by Ad5/F35 Adenoviral Vector is Dependent on the Cumulative Cellular Conditions of Survival and Autophagy

Overview
Journal Int J Oncol
Specialty Oncology
Date 2013 Feb 14
PMID 23403990
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

To overcome the poor tumor transduction efficiency of adenovirus serotype 5 (Ad5) observed in several types of cancer, the fiber region of Ad5, apart from its tail, was replaced by adenovirus serotype 35 (Ad35). The chimeric Ad5/F35 adenoviral vector did not exhibit any significant enhancement of transduction efficiency. CD46, a receptor for Ad35, was expressed in relatively small amounts in most of the cancer cells examined. Therefore, we investigated the pivotal factor(s) that render cancer cells susceptible to transduction. We discovered that the tumor transduction efficiency of Ad5/F35 was enhanced in the presence of rapamycin, an autophagy inducer, in some cancer cells. Analysis of survival potential and cell proliferation rates revealed that Ad5/F35 exerted a more pronounced oncolytic effect in cancer cells with higher survival potential in the presence of rapamycin.

Citing Articles

Expanding the Scope of Adenoviral Vectors by Utilizing Novel Tools for Recombination and Vector Rescue.

Fischer J, Fedotova A, Buhler C, Darriba L, Schreiner S, Ruzsics Z Viruses. 2024; 16(5).

PMID: 38793540 PMC: 11125593. DOI: 10.3390/v16050658.


Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways.

Zhu Z, McGray A, Jiang W, Lu B, Kalinski P, Guo Z Mol Cancer. 2022; 21(1):196.

PMID: 36221123 PMC: 9554963. DOI: 10.1186/s12943-022-01664-z.


Current landscape and perspective of oncolytic viruses and their combination therapies.

Su Y, Su C, Qin L Transl Oncol. 2022; 25:101530.

PMID: 36095879 PMC: 9472052. DOI: 10.1016/j.tranon.2022.101530.


Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors.

Su Y, Li J, Ji W, Wang G, Fang L, Zhang Q J Immunother Cancer. 2022; 10(5).

PMID: 35609942 PMC: 9131115. DOI: 10.1136/jitc-2022-004691.


Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer.

Zahedi-Amiri A, Malone K, Beug S, Alain T, Yeganeh B Cells. 2021; 10(10).

PMID: 34685652 PMC: 8534833. DOI: 10.3390/cells10102672.